Curexo Inc. (KOSDAQ:060280)
South Korea · Delayed Price · Currency is KRW 9,010.00
+30.00 (0.33%)
Aug 20, 2026, 3:30 PM KST
Curexo Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
Revenue Revenue Growth | 77,741 | 74,532 | 55,531 | 27,530 | 26,138 | 31,091 |
Revenue Growth | 20.38% | 34.22% | 101.72% | 5.33% | -15.93% | 28.05% |
Gross Profit Gross Profit Growth | 26,444 | 24,823 | 14,618 | 2,404 | 3,363 | 3,903 |
Operating Income Operating Income Growth | 3,248 | 2,362 | -5,822 | -24,759 | -20,733 | -14,041 |
Net Income Net Income Growth | 5,512 | 2,771 | -8,758 | -9,402 | -10,859 | -7,465 |
Earnings Per Share EPS Growth | 132.08 | 67.00 | -213.18 | -353.39 | -408.00 | -281.00 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
Trade Division Trade Division Growth | 25,560 | 26,436 | 22,974 | 23,282 | 28,625 |
Implant Division Implant Division Growth | 12,600 | 9,769 | - | - | - |
Medical Robot Division Medical Robot Division Growth | 36,372 | 19,327 | 4,555 | 2,856 | 2,466 |
Total Total Growth | 74,532 | 55,531 | 27,530 | 26,138 | 31,091 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
Cash & Investments Cash & Investments Growth | 26,462 | 20,007 | 33,481 | 18,248 | 7,110 | 7,967 |
Total Debt Total Debt Growth | 1,250 | 1,166 | 1,586 | 3,000 | 21,984 | 2,118 |
Net Cash (Debt) Net Cash Growth | 25,211 | 18,840 | 31,896 | 15,248 | -14,874 | 5,849 |
Net Cash Growth | 3.46% | -40.93% | 109.18% | - | - | -74.44% |
Net Cash Per Share Net Cash Per Share Growth | 605.56 | 457.55 | 776.19 | 573.09 | -558.85 | 220.16 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
Operating Cash Flow Operating Cash Flow Growth | 759.36 | -11,258 | 3,850 | -19,789 | -20,061 | -14,579 |
Capital Expenditures CapEx Growth | -676.24 | -2,484 | -3,384 | -3,054 | -2,080 | -816.92 |
Free Cash Flow Free Cash Flow Growth | 83.12 | -13,742 | 465.3 | -22,843 | -22,141 | -15,396 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
Gross Margin | 34.02% | 33.31% | 26.32% | 8.73% | 12.87% | 12.55% |
Operating Margin | 4.18% | 3.17% | -10.48% | -89.94% | -79.32% | -45.16% |
Pretax Margin | 7.25% | 3.80% | -15.61% | -90.87% | -85.19% | -46.94% |
Profit Margin | 7.09% | 3.72% | -15.77% | -34.15% | -41.55% | -24.01% |
FCF Margin | 0.11% | -18.44% | 0.84% | -82.98% | -84.71% | -49.52% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
PE Ratio | 68.21 | 192.14 | - | - | - | - |
P/FCF Ratio | 4472.53 | - | 570.48 | - | - | - |
PS Ratio | 4.78 | 7.15 | 4.78 | 5.94 | 4.99 | 3.94 |